Authors
Latest:
Reducing Prescription Drug Costs for Seniors: The ABCs of ASP for Part DOutlining the steps to a payment approach for Medicare Part D drugs that provides savings for patients.
Latest:
Rx Power Struggle: How Pharma can Flip the PBM ScriptThe industry holds the key to true change to the drug access landscape.
Latest:
A ‘Sign’ of the Times: Digital Contract TransformationThe pandemic has raised the stakes for companies pursuing new data-harnessing capabilities in contract management and KPI benchmarking and tracking.
Latest:
Key Considerations for Senior Executives Related to Quality CultureExploring practical points to further understand and strengthen quality culture.
Latest:
Best Practices to Ensure Sourcing and Outsourcing Are Strategic Levers for Competitive AdvantageOptimally designed SSO program can allow companies to deliver therapies to patients faster and at a more affordable cost.
Latest:
It’s Time to Invest in Reproductive Medicine and Maternal HealthAmidst lack of funding for women’s health research, industry must collaborate now to advance RMMH.
Latest:
The Learning Advantage: How Strategic L&D Can Optimize Pharma Rotational Programs for SuccessCompanies offering post-grad rotational programs develop broad skillsets in new hires.
Latest:
Next-Gen Partnerships: The Ascent of Advanced TherapiesWith added push from the COVID-19 pandemic, investment in promising RNA- and cell and gene therapy-based treatments and technology via industry dealmaking is growing considerably.
Latest:
Leveraging Market Research & User Experience Research in Life SciencesThe right market research insights provide a richer, more-nuanced picture of your customers as people, not just as numbers on a spreadsheet.
Latest:
Medical Affairs: Support Function or Competitive Advantage? How AI & NLP Can Ensure It is BothTreating medical affairs solely as a support function is penny-wise and pound foolish. With the advent of machine learning, the medical affairs team can innovate and perform their many functions better and more efficiently.
Latest:
Building Resiliency: Essential Leadership Principles for 2024Embracing business imperatives such as operational efficiency and a focus on a patient-centric approach can help pharma leaders provide a stable foundation amid lingering uncertainty.
Latest:
Rethinking Unmet Patient Medical Needs Through the Lens of the Patient JourneyBiopharma companies can foster patient-centered innovation by focusing on unmet needs along each stage of the patient journey while collaborating with key stakeholders directly or indirectly responsible for disease management.
Latest:
The State of Plastics Recycling in BioPharmaKey Challenges for Manufacturers and How MilliporeSigma is Leading Industry-Wide Change
Latest:
Just How ‘Real’ is Real-World Data?Addressing sources of tension on differentiating types of data.
Latest:
Biopharma Medical Affairs: Where We’ve Been and Where We’re HeadedA discussion with medical leaders on the present and future state of this vital biopharmaceutical function.
Latest:
Advancing COPD Research: Harnessing Wearable Sensors and Remote Monitoring for Improved InsightsWearable sensors and remote monitoring technology can help HCPs monitor and manage COPD more effectively.
Latest:
2024 Pipeline Report: First-World FocusPharm Exec’s 19th annual report on the trends of the day in drug development examines the surging investment in new treatments and advances for so-called “first-world” conditions, capturing the landscape of five expanding therapeutic areas: weight loss, osteoarthritis, Alzheimer’s disease, COPD, and psychedelics.
Latest:
Recent Federal Circuit Developments in Patent LicensingUnderstanding of recent legal developments can help companies avoid infringement.
Latest:
AI: A Value Advantage? Maximizing Your Brand OutreachPractical ways product teams can leverage the benefits of generative artificial intelligence as a strategic advantage in pharmaceutical and life sciences commercialization.
Latest:
Pharma and AI: 2021 and BeyondFerdi Steinmann looks at pharma's current relationship with AI and how it is set to evolve.
Latest:
Bringing Biosimilars to Market in EuropeIf the life sciences sector can support healthcare professionals to gain confidence in substituting original treatments with new biosimilars, prices will reduce and patient outcomes will be enhanced.
Latest:
Viable Options: Packaging and Partnering for Successful Storage and Transport of Conventional Cold-Chain Vaccines for Covid-19***Live: Thursday, February 25, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET*** As strategic planning among manufacturers and logistics partners commences, this webinar will serve as a platform to discuss service offerings and explore the most effective possible solutions. *** On demand until Feb. 25, 2022***
Latest:
FDA Inspection and Enforcement Developments During the COVID-19 PandemicMitigating the risks of development, authorization, and marketing for new therapies following "new normal" created by COVID-related violations.
